Administrative hurdles can drown physicians in paperwork while preventing patients from getting the right drug at the right time. Check out the resources below about how this impacts patients, providers, and others, and what can be done to make it better.
Learn how CVP Physicians achieves better prior authorization outcomes including faster payer turnaround and fewer denials with SamaCare.
Learn how Articularis Healthcare Group, the largest rheumatology specialty group in the U.S., leveraged SamaCare for 56% faster payer turnaround time.
Learn how one of the top neurologic institutes in the U.S. leverages SamaCare to rapidly scale prior authorization management to keep up with their growing practice.
Tennessee Oncology partners with SamaCare to reduce operational expenses associated with prior authorizations.
Within 3 months, Tennessee Cancer Specialists reduced prior authorization resolution time by 60% with SamaCare.
SamaCare partners with American Rheumatology Network (ARN) to bring streamlined prior authorization to national network of over 460 community-based providers.
Medical practices can now seamlessly transfer data between NextGen® EHR and SamaCare's prior authorization platform.
We summarize important prior authorization takeaways from the House Committee on Energy & Commerce oversight hearing on Medicare Advantage plans.
As practices face staffing shortages, maximizing existing resources has never been more important. Read on to learn how practices can save time on a weekly basis.
How prevalent is the use of electronic prior authorizations across retina, oncology, and neurology specialties? Read on to find out.
We took a look at how oncology practices are faring when it comes to prior authorization management compared to other specialties. Read on for survey results.
The results of SamaCare's second annual provider market access survey are in. Read our blog post for year-over-year changes, and full survey results.
SamaCare expands into neurology, partnering with Texas Neurology, DENT Neurologic Institute, and Savannah Neurology
What data should payers publish on prior authorization? We explore impactful metrics in this second article examining the implications of recent legislation.
Practice management experts from Oncology Consultants of Houston and Tennessee Cancer Specialists discuss how they streamline prior authorizations. Watch on-demand.
SamaCare examines the impact electronic prior authorizations have on patient care, and why this is an important part of the Improving Seniors' Timely Access to Care Act.
Experts from Associated Retinal Consultants in Michigan and Southwest Eye Consultants, PLLC, in Colorado join SamaCare to discuss managing retina payor mix.
Read our survey to learn how prior authorizations are impacting providers' experience administering specialty drugs.
Pharmaceutical Commerce covers the results of SamaCare's 2021 Specialty Drug Patient Access study.
See what UHC's new prior authorization requirements mean for your retina practice, and how to mitigate additional time requirements.
Check out SamaCare's 7-step checklist for efficient and effective prior authorization submissions.
How does the prior authorization process impact patients? We surveyed providers to understand the human cost of delayed prior authorizations.
Over the past two years helping hundreds of physicians navigate the burden of prior authorizations for physician administered medications, we’ve learned a lot.
Oncology Consultants used RPA to improve prior authorization for physician-administered Rx, resulting in time saved, reduction in treatment delay, & better patient care.
Following our April survey, SamaCare fielded a second survey to measure the ongoing impact of COVID-19 on community practices.
Market access teams face a "monkey-in-the-middle" problem when trying to help with the challenges of prior authorization. Here's how they can help.
Most prior authorizations get resolved without a problem. But the "wayward" authorizations can create huge headaches for practices.
How community practices across the country have responded to COVID-19.
How the number of Prior Authorization "hops" can impact (and harm) patient care.
Utilization management already weighs heavily on providers and will continue to worsen. Practices must find ways to reduce that burden.